Glenmark Pharmaceuticals (GLENMARK.BO) Earnings Analysis
Glenmark Pharmaceuticals (GLENMARK.BO) next reports earnings on 2026-07-31, consensus EPS 17.3 INR. Last quarter (2026-06-01) it missed with EPS 10.68 INR vs 18.2 INR est (-41.3%). It has beaten estimates in 1/7 recent quarters (14%). Trailing P/E 45.61.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GLENMARK.BO next report earnings?
| Next earnings date | 2026-07-31 |
|---|---|
| Consensus EPS estimate | 17.3 INR |
| Revenue estimate | 39.17B |
GLENMARK.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-01 | 10.68 INR | 18.2 INR | -41.3% | Miss |
| 2026-02-12 | 14.28 INR | 18.7 INR | -23.6% | Miss |
| 2025-11-14 | 21.62 INR | n/a | n/a | n/a |
| 2025-08-13 | 1.66 INR | 12.9 INR | -87.1% | Miss |
| 2025-05-23 | 8.75 INR | 12.1 INR | -27.7% | Miss |
| 2025-02-13 | 12.3 INR | 14.05 INR | -12.5% | Miss |
| 2024-11-14 | 12.55 INR | 14.7 INR | -14.6% | Miss |
| 2024-08-14 | 12.06 INR | 11.7 INR | +3.1% | Beat |
Beat rate: 1/7 (14%) over reported quarters with consensus data.
GLENMARK.BO valuation and analyst view
| Trailing P/E | 45.61 |
|---|---|
| Trailing EPS | 48.254 INR |
| Price / book | 5.91 |
| Dividend yield | 0.11% |
| Market cap | 620.39B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Glenmark Pharmaceuticals (GLENMARK.BO)'s next earnings date?
Glenmark Pharmaceuticals is next scheduled to report on 2026-07-31, with a consensus EPS estimate of 17.3 INR and revenue estimate of 39.17B.
Did GLENMARK.BO beat earnings last quarter?
In its 2026-06-01 report, GLENMARK.BO posted EPS of 10.68 INR versus a 18.2 INR estimate — a miss of 41.3%.
What is GLENMARK.BO's earnings track record?
Over the last 7 reported quarters with consensus data, GLENMARK.BO beat estimates 1 times (14%).
What is GLENMARK.BO's current P/E ratio and EPS?
GLENMARK.BO trades at a trailing P/E of 45.61 on trailing EPS of 48.25443000747636 INR.
What do analysts rate GLENMARK.BO?
GLENMARK.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.